Transcatheter Market By Product Type (Transcatheter Heart Valve Replacement (TAVR) Devices {TAVR Valve Prostheses, TAVR Accessories}, Transcatheter Aortic Valve Repair (TAVR) Devices {Valvuloplasty Balloons, Valve Repair Patches}, Transcatheter Mitral Valve Repair Devices {Mitral Valve Repair Clips, Mitral Valve Replacement Devices, Mitral Valve Repair Stents}, Transcatheter Embolization Devices {Coils, Micro-Embolization Devices, Balloon Occlusion Devices}, Catheters {Diagnostic Catheters, Interventional Catheters, Electrophysiology Catheters}, Stents {Coronary Stents, Peripheral Stents}, Other), By Application (Cardiovascular {Aortic Valve Diseases, Mitral Valve Diseases, Coronary Artery Disease, Congenital Heart Defects, Arrhythmias}, Neurovascular {Carotid Artery Disease, Cerebral Aneurysms, Intracranial Stenting}, Peripheral Vascular Diseases {Peripheral Artery Disease (PAD), Venous Occlusion}), By Material (Nitinol, Stainless Steel, Cobalt-Chromium), By Delivery Method (Percutaneous Delivery, Transvenous Delivery, Endovascular Delivery), and By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Cardiovascular Centers, Outpatient Facilities), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Transcatheter market accounted for USD 15.9 Billion in 2024 and is expected to reach USD 53.7 Billion by 2035, growing at a CAGR of around 11.7% between 2025 and 2035. The transcatheter market can be defined as the medical industry segment that deals with catheters and other related devices used to diagnose and treat cardiovascular, neurovascular, and peripheral vascular disorders through minimally invasive procedures.

Essential procedures are transcatheter heart valve replacement also known as TAVR, transcatheter aortic valve repair or TAVR, and embolization. These devices are employed in procedures including heart valve repair and replacement; treatment of coronary artery diseases; and neurovascular interventions. The growth has been fueled by technological improvements within the healthcare industry, the expansion of minimally invasive methods, and the growing prevalence of cardiovascular disorders.

Report Scope:

Market Dynamics

Rising Demand for Minimally Invasive Procedures Drives Transcatheter Market Growth

The transcatheter market is expanding as patients and healthcare practitioners prefer fewer traumatic procedures that make quick recovery possible and have comparatively fewer complications. Transcatheter procedures like TAVR and Transcatheter embolization are less invasive treatments for such heart disorders as valve diseases, and coronary artery diseases, among others.

While using such procedures in their profession, the transcatheter market is gradually growing worldwide due to the importance of using methods other than open surgeries. With time, patients are adopting transcatheter procedures because they reduce hospitalization and time to recover more than traditional procedures. The increasing need for such solutions is among the leading forces behind the transcatheter market expansion, with more patients turning to safer and more effective treatments. Due to decreasing weight and improved comfort for patients, the transcatheter market is expected to expand in the years ahead.

Technological Advancements in Transcatheter Applications Fuel Market Expansion Worldwide

One of the growth factors that have been observed to be encouraging the growth of the transcatheter market across the globe is technological development. Increased technology in the devices leads to enhanced accuracy, safety, and efficiency of the procedures for addressing complicated Cardiovascular and Neurovascular illnesses. For instance, nitinol and cobalt-chromium give better flexibility, durability, and strength that improves the device's performance.

Technology improvement in imaging, robotic guidance, and catheter navigation has enhanced the success of transcatheter procedures. With the advancement of these technologies, and expansion in the areas that can be treated through transcatheters, the market also expands. Transcatheter diagnosis and therapeutic interventions themselves have been improved with the help of AI and machine learning. The ancillary demand for high caliber effective treatments across the world plays some role in the remarkable growth of the transcatheter market.

High Costs of Transcatheter Applications Hinder Market Growth in Emerging Regions

Although the transcatheter market is growing internationally, the prohibitive price of transcatheter procedures has become a factor challenging its development in the emerging market. The technology applied in transcatheter devices, and the quality materials used to construct them make it expensive for a large population in low and middle-income countries. Also, the training required, and the specific skill set required as regards performing transcatheter procedures form another factor in the cost equation. Devices such as TAVR valves, stents, and embolization tools are expensive for patients particularly in emerging markets due to the high costs of manufacturing. To address this, cost containment of transcatheter applications and integration of health insurance, governmental subsidy, and partnership are key to expanding this solution in those regions.

Growing Geriatric Population Presents Significant Growth Opportunities for Transcatheter Market

When people grow older, more of them become vulnerable to cardiovascular diseases like aortic stenosis and valve disorders. Most elderly patients cannot undergo conventional open-heart operations because of their medical condition and TAVR is a less invasive procedure. Minimally invasive procedures including TAVR differ from conventional surgery since they minimally invade the body and transcatheter treatments provide elderly patients with shorter recovery periods, low risk of surgery, and much more improved outcomes than open surgery. Similarly, as the geriatric population is growing, there is a growing need for such minimally invasive sophisticated procedures, which contribute to a growing transcatheter market offering. It explains the high potential for creating new specific transcatheter systems required for elderly patients.

Expanding Healthcare Infrastructure in Developing Nations Boosts Transcatheter Application Demand

The medical facilities of developing countries have been enhanced at a fast pace by investing in modern techniques and facilities. With improving health standards worldwide these countries are embracing sophisticated therapeutic interventions such as transcatheter techniques to deal with rising cardiovascular diseases. Peripheral interventions like TAVR and TMVR are becoming more common because they use catheters to get to the heart, so the patient has less pain, gets to leave the hospital faster, and has fewer issues than the surgical approach. With increasing healthcare access in these regions, more patients will be able to access these treatments, increasing the demand for transcatheter-based devices and therapies and catalyzing the progress of the transcatheter market. This growing healthcare capacity is the reason countries are gradually making these life-saving treatments available to more of their population.

Industry Experts Opinion

“The use of a temporary-permanent pacemaker has advantages in the management of conduction disturbances after TAVR. The active fixation lead offers a retractable helix with extraordinary flexibility and an extended scope for regular monitoring and pulse generator interrogation. Vascular access to the internal jugular or subclavian veins enables rapid ambulation after the procedure without increasing hospitalization length while ensuring greater patient comfort and mobility; patients undergoing temporary-permanent pacemaker implantation can be discharged early to resume normal daily activities.”

• Sanshuai Chang, MD, a valvular heart disease specialist at Beijing AnZhen Hospital

Segment Analysis

Based on the product type, the transcatheter market has been classified into Transcatheter Heart Valve Replacement (TAVR) Devices, Transcatheter Aortic Valve Repair (TAVR) Devices, Transcatheter Mitral Valve Repair Devices, Transcatheter Embolization Devices, Catheters and others. By product type, Transcatheter Heart Valve Replacement (TAVR) Devices are the largest segment, including TAVR valve prostheses and accessories for patients with aortic valve diseases. TAVR is a less invasive technique for the replacement of valves and is more and more used in older and higher-risk patient populations. Other notable products in this segment include Transcatheter Aortic Valve Repair (TAVR) Devices including valvuloplasty balloons and these are surgically used to repair aortic valves in patients who cannot undergo regular surgical repair. Transcatheter Mitral Valve Repair Devices like Mitral Valve repair clips, Replacement Devices, and repair stents are also a must-have addressing mitral valve diseases. Further, Transcatheter Embolization Devices, such as coils and micro-embolization devices provide important solutions in neurovascular and vascular illnesses. It also contains catheters for diagnostic, interventional, and electrophysiology use, and stents for coronary and peripheral applications, which are important for several cardiovascular and peripheral vascular applications.

Based on the application, the transcatheter market is divided into Cardiovascular, Neurovascular, and Peripheral Vascular Diseases. The transcatheter market is focused on cardiovascular diseases such as aortic and mitral valve diseases, coronary artery disease, congenital heart defects, and arrhythmias. These conditions create a larger need for transcatheter procedures, particularly for aortic stenosis and valve replacements. The neurovascular segment is another expanding territory, focusing on carotid artery disease, cerebral aneurysms, and intracranial stenting. The growing incidence of these diseases and the development of transcatheter technologies are likely to complicate neurovascular interventions. Subsequently, peripheral vascular diseases such as peripheral artery disease and venous occlusion are observed to be growing due to a growing prevalence of diseases and patients prefer minimally invasive surgeries for improved results. All these segments are already helping to drive growth in the transcatheter market by improving the chances of wider use through innovations and specialization.

Regional Analysis

North America, especially the United States is the largest and the most developed transcatheter market including TAVR technologies. This market is fueled by a higher incidence of cardiovascular diseases, the development of the healthcare industry, and increased focus from authorities for heart-related products with FDA approvals for devices. The United States is the global leader in adopting minimally invasive treatments; driven by an aging population and the need to address heart disease. So, in North America, the level of highly concentrated major medical device manufacturers, and advanced development in transcatheter technologies support this conclusion.

The Asia-Pacific (APAC) region is identified to be the fastest-growing transcatheter market. This growth is due to demographic factors including a large aging population a factor that is illustrated in Asian countries such as Japan, China, and India. The rising rate of cardiovascular diseases, better healthcare facilities and frameworks that are coming up, and the need for better treatments such as TAVR are what contribute to the growth of the market. The market for these transcatheter procedures is likely to continue to expand within the Asia Pacific region because healthcare systems in the region are improving, and patients are gaining greater access to these innovative technologies.

Competitive Landscape

The transcatheter market comprises a few targeted companies which include Medtronic, Edwards Lifesciences, Boston Scientific, Abbott Laboratories, and Terumo Corporation. Current leading products include Medtronic’s Evolut TAVR system and Edwards Lifesciences' SAPIEN family of valves as it offered a high bar in the TAVR segment. Boston Scientific comes with its new lotus edge valve which is more precise, and Abbott has risen to the occasion with its MitraClip for mitral valve repair. Terumo is growing in Asia by offering TAVR solutions.

To retain their market dominance in a fast-growing market segment these companies are concentrating on technological advancement, increased product offerings, and device approval, coupled with enhancement of clinical success rates. Further, collaboration, acquisition, and regional expansion are some of the core strategies being practiced for enhancing the market positions.

Transcatheter Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In April 2024, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's first-of-its-kind TriClip™ transcatheter edge-to-edge repair (TEER) system that is specifically designed for the treatment of tricuspid regurgitation (TR), or a leaky tricuspid valve.
• In February 2024, the FDA approved the Evoque transcatheter tricuspid valve replacement system, this device is based on the results of the TRISCEND II trial. The device can significantly improve TR grade and functional status and can virtually eliminate TR in many patients.

Report Coverage:

By Product Type

• Transcatheter Heart Valve Replacement (TAVR) Devices
  • TAVR Valve Prostheses
  • TAVR Accessories
• Transcatheter Aortic Valve Repair (TAVR) Devices
  • Valvuloplasty Balloons
  • Valve Repair Patches
• Transcatheter Mitral Valve Repair Devices
  • Mitral Valve Repair Clips
  • Mitral Valve Replacement Devices
  • Mitral Valve Repair Stents
• Transcatheter Embolization Devices
  • Coils
  • Micro-Embolization Devices
  • Balloon Occlusion Devices
• Catheters
  • Diagnostic Catheters
  • Interventional Catheters
  • Electrophysiology Catheters
• Stents
  • Coronary Stents
  • Peripheral Stents
• Other

By Application

• Cardiovascular
  • Aortic Valve Diseases
  • Mitral Valve Diseases
  • Coronary Artery Disease
  • Congenital Heart Defects
  • Arrhythmias
• Neurovascular
  • Carotid Artery Disease
  • Cerebral Aneurysms
  • Intracranial Stenting
• Peripheral Vascular Diseases
  • Peripheral Artery Disease (PAD)
  • Venous Occlusion

By Material

• Nitinol
• Stainless Steel
• Cobalt-Chromium

By Delivery Method

• Percutaneous Delivery
• Transvenous Delivery
• Endovascular Delivery

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Cardiovascular Centers
• Outpatient Facilities

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Abbott Laboratories
• Medtronic
• Boston Scientific Corporation
• Johnson & Johnson
• Terumo Corporation
• Edwards Lifesciences Corporation
• Biotronik
• Intuitive Surgical
• MicroPort Scientific Corporation
• LivaNova
• Cook Medical
• Siemens Healthineers
• Philips Healthcare
• Stereotaxis
• Vascular Solutions
• AtriCure
• Abiomed
• Cardinal Health